Last reviewed · How we verify
NCT07103772
Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome
NA trial testing Ananá in Irritable Bowel Syndrome in 94 participants. Enrolling by invitation.
14 March 2025
Quick facts
| Lead sponsor | Universidad Autonoma de Nuevo Leon |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 94 |
| Start date | 14 March 2024 |
| Primary completion | 14 March 2025 |
| Estimated completion | 15 March 2026 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Ananá
Conditions studied
- Irritable Bowel Syndrome — all drugs for Irritable Bowel Syndrome →
- Irritable Bowel Syndrome With Diarrhea — all drugs for Irritable Bowel Syndrome With Diarrhea →
- Irritable Bowel Syndrome With Constipation — all drugs for Irritable Bowel Syndrome With Constipation →
- Irritable Bowel Syndrome Mixed — all drugs for Irritable Bowel Syndrome Mixed →
Sponsor
Universidad Autonoma de Nuevo Leon — full company profile →
Who can join
18 and older, any sex, with Irritable Bowel Syndrome or Irritable Bowel Syndrome With Diarrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Irritable bowel syndrome is characterized by the presence of chronic, recurrent abdominal pain, alterations in bowel habits, and abdominal distension. The medical diagnosis is made using the Rome IV criteria. There are three IBS phenotypes: diarrhea-predominant, constipation-predominant, and mixed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07103772
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Irritable Bowel Syndrome
Currently open trials in the same condition.
- NCT07235228 — Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients · NA · recruiting
- NCT07421011 — Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 · Phase 1 · recruiting
- NCT07360938 — Drug Interaction Potential of Pro-Inflammatory Conditions · recruiting
- NCT06788444 — Efficacy of Esketamine for Patients With Irritable Bowel Syndrome · NA · recruiting
- NCT07484412 — Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms · NA · active not recruiting
Other Universidad Autonoma de Nuevo Leon trials
Trials by the same sponsor.
- NCT07449000 — Losartan for Corneal Fibrosis · NA · recruiting
- NCT07497555 — Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-G · NA · recruiting
- NCT06824922 — "Educational Intervention 'Be Yourself': Digital Innovation to Prevent Teenage Pregnancy" · NA · not yet recruiting
- NCT06861478 — PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease · Phase 2 · recruiting
- NCT06617299 — Cognitive-behavioral Intervention to Increase the Practice of Responsive Feeding and Maintain Healthy Weight in Infants · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07103772 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Nuevo Leon
- Last refreshed: 2 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07103772.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing